SNAP-25 gene polymorphisms and weight gain in schizophrenic patients

Journal of Psychiatric Research
Richard MusilBrigitta Bondy

Abstract

Drug induced weight gain is a serious side effect of several atypical antipsychotics. As genetic factors play an important role in the homeostasis of hunger/satiety we tried to replicate a preliminary previous finding about an impact of three polymorphisms in the synaptosomal-associated protein of 25kDa (SNAP-25; sites MnlI, TaiI and DdelI in the 3(')-UTR) on clinical response and antipsychotic induced weight gain. We genotyped 162 schizophrenic patients being treated in monotherapy with atypical antipsychotics and 312 healthy control subjects for the three polymorphisms in the SNAP-25 gene using PCR. PANSS scores and weight were measured weekly for a minimum of five weeks. We found significant associations between the TaiI and MnlI polymorphisms and serum triglyceride levels at baseline and for the DdelI polymorphism and weight gain. In conclusion our study can at least partly replicate the previous findings concerning the impact of SNAP-25 gene polymorphisms on weight gain during antipsychotic treatment.

References

Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·G SchiavoT H Söllner
Mar 26, 1998·Biological Psychiatry·P M ThompsonN I Perrone-Bizzozero
Jul 31, 2001·Journal of Clinical Psychopharmacology·J P LindenmayerA Iskander
Sep 28, 2002·Human Molecular Genetics·Vincenzo S BasileJames L Kennedy
Dec 14, 2002·Lancet·Vincenzo S BasileJames L Kennedy
Apr 2, 2003·The American Journal of Psychiatry·Gavin P ReynoldsXiaoBin Zhang
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter M ThompsonMarquis P Vawter
Jun 20, 2003·Biological Psychiatry·Peter M ThompsonDaniel P van Kammen
Aug 2, 2003·Molecular Membrane Biology·Thomas H Söllner
Jun 19, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Daniel J MüllerJames L Kennedy
Sep 10, 2004·Journal of Clinical Psychopharmacology·Henry A Nasrallah, John W Newcomer
Dec 17, 2004·Human Genomics·Frank Dudbridge
Jan 7, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Del D MillerStephan Arndt
Apr 19, 2005·Obesity Research·Louis PérusseClaude Bouchard
Oct 20, 2005·Drugs of Today·Rosane Ness-Abramof, Caroline M Apovian
Dec 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Robert B ZipurskyJeffrey A Lieberman
Jan 20, 2006·International Clinical Psychopharmacology·Staffan HäggRolf Adolfsson
Feb 7, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·T BottaiE Perrin

❮ Previous
Next ❯

Citations

Feb 13, 2009·Der Nervenarzt·D J MüllerA Heinz
Dec 17, 2011·European Archives of Psychiatry and Clinical Neuroscience·Nenad VasicJohannes Brettschneider
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Vilte E BarakauskasWilliam G Honer
Aug 30, 2008·Schizophrenia Bulletin·Maria J Arranz, Shitij Kapur
May 30, 2009·Diabetes, Obesity & Metabolism·Richard I G Holt, Robert C Peveler
Aug 17, 2011·Pharmacogenomics·Arne J RisseladaToine C G Egberts
Jul 20, 2011·BMC Psychiatry·Michael ObermeierFlorian Seemüller
Jul 22, 2015·Proceedings of the National Academy of Sciences of the United States of America·Ismael Valladolid-AcebesChristina Bark
May 23, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sergi MasAmalia Lafuente
Dec 2, 2015·Schizophrenia Research·Stefanie Malan-MüllerSoraya Seedat
Jan 19, 2016·Journal of Diabetes Research·Nasser M Al-DaghriFranca R Guerini
Jun 18, 2011·Journal of Psychiatric Research·Adam WichniakMarek Jarema
May 11, 2011·Electrophoresis·Reka Kovacs-NagyZsolt Ronai
Aug 30, 2008·Journal of Neural Transmission·Harald ScherkOliver Gruber
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Dec 14, 2018·European Archives of Psychiatry and Clinical Neuroscience·Sophie K KirchnerSergi Papiol
Jun 3, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Eva J BrandlDaniel J Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.